K945610

Substantially Equivalent

ABUSIGN(TM) AMP, DOA-AMP, ACCUSIGN(TM) AMP-DOA-AMP, BIOSIGN(TM) AMP, DOA-AMP

Applicant: Princeton BioMeditech Corp.
Product code: DKZ
Advisory panel: Clinical Toxicology
Date received: 1994-11-15
Decision date: 1995-04-13
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Princeton, NJ, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.